Cargando…
The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
The gut microbiota plays a fundamental role in human nutrition and metabolism and may have direct implications for type 2 diabetes and associated preconditions. An improved understanding of relations between human gut microbiota and glucose metabolism could lead to novel opportunities for type 2 dia...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535511/ https://www.ncbi.nlm.nih.gov/pubmed/36026526 http://dx.doi.org/10.1093/ajcn/nqac217 |
_version_ | 1784802788230823936 |
---|---|
author | Palmnäs-Bédard, Marie S A Costabile, Giuseppina Vetrani, Claudia Åberg, Sebastian Hjalmarsson, Yommine Dicksved, Johan Riccardi, Gabriele Landberg, Rikard |
author_facet | Palmnäs-Bédard, Marie S A Costabile, Giuseppina Vetrani, Claudia Åberg, Sebastian Hjalmarsson, Yommine Dicksved, Johan Riccardi, Gabriele Landberg, Rikard |
author_sort | Palmnäs-Bédard, Marie S A |
collection | PubMed |
description | The gut microbiota plays a fundamental role in human nutrition and metabolism and may have direct implications for type 2 diabetes and associated preconditions. An improved understanding of relations between human gut microbiota and glucose metabolism could lead to novel opportunities for type 2 diabetes prevention, but human observational studies reporting on such findings have not been extensively reviewed. Here, we review the literature on associations between gut microbiota and markers and stages of glucose dysregulation and insulin resistance in healthy adults and in adults with metabolic disease and risk factors. We present the current evidence for identified key bacteria and their potential roles in glucose metabolism independent of overweight, obesity, and metabolic drugs. We provide support for SCFAs mediating such effects and discuss the role of diet, as well as metabolites derived from diet and gut microbiota interactions. From 5983 initially identified PubMed records, 45 original studies were eligible and reviewed. α Diversity and 45 bacterial taxa were associated with selected outcomes. Six taxa were most frequently associated with glucose metabolism: Akkermansia muciniphila, Bifidobacterium longum, Clostridium leptum group, Faecalibacterium prausnitzii, and Faecalibacterium (inversely associated) and Dorea (directly associated). For Dorea and A. muciniphila, associations were independent of metabolic drugs and body measures. For A. muciniphila and F. prausnitzii, limited evidence supported SCFA mediation of potential effects on glucose metabolism. We conclude that observational studies applying metagenomics sequencing to identify species-level relations are warranted, as are studies accounting for confounding factors and investigating SCFA and postprandial glucose metabolism. Such advances in the field will, together with mechanistic and prospective studies and investigations into diet–gut microbiota interactions, have the potential to bring critical insight into roles of gut microbiota and microbial metabolites in human glucose metabolism and to contribute toward the development of novel prevention strategies for type 2 diabetes, including precision nutrition. |
format | Online Article Text |
id | pubmed-9535511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95355112022-10-07 The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs Palmnäs-Bédard, Marie S A Costabile, Giuseppina Vetrani, Claudia Åberg, Sebastian Hjalmarsson, Yommine Dicksved, Johan Riccardi, Gabriele Landberg, Rikard Am J Clin Nutr Narrative Review The gut microbiota plays a fundamental role in human nutrition and metabolism and may have direct implications for type 2 diabetes and associated preconditions. An improved understanding of relations between human gut microbiota and glucose metabolism could lead to novel opportunities for type 2 diabetes prevention, but human observational studies reporting on such findings have not been extensively reviewed. Here, we review the literature on associations between gut microbiota and markers and stages of glucose dysregulation and insulin resistance in healthy adults and in adults with metabolic disease and risk factors. We present the current evidence for identified key bacteria and their potential roles in glucose metabolism independent of overweight, obesity, and metabolic drugs. We provide support for SCFAs mediating such effects and discuss the role of diet, as well as metabolites derived from diet and gut microbiota interactions. From 5983 initially identified PubMed records, 45 original studies were eligible and reviewed. α Diversity and 45 bacterial taxa were associated with selected outcomes. Six taxa were most frequently associated with glucose metabolism: Akkermansia muciniphila, Bifidobacterium longum, Clostridium leptum group, Faecalibacterium prausnitzii, and Faecalibacterium (inversely associated) and Dorea (directly associated). For Dorea and A. muciniphila, associations were independent of metabolic drugs and body measures. For A. muciniphila and F. prausnitzii, limited evidence supported SCFA mediation of potential effects on glucose metabolism. We conclude that observational studies applying metagenomics sequencing to identify species-level relations are warranted, as are studies accounting for confounding factors and investigating SCFA and postprandial glucose metabolism. Such advances in the field will, together with mechanistic and prospective studies and investigations into diet–gut microbiota interactions, have the potential to bring critical insight into roles of gut microbiota and microbial metabolites in human glucose metabolism and to contribute toward the development of novel prevention strategies for type 2 diabetes, including precision nutrition. Oxford University Press 2022-08-26 /pmc/articles/PMC9535511/ /pubmed/36026526 http://dx.doi.org/10.1093/ajcn/nqac217 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Narrative Review Palmnäs-Bédard, Marie S A Costabile, Giuseppina Vetrani, Claudia Åberg, Sebastian Hjalmarsson, Yommine Dicksved, Johan Riccardi, Gabriele Landberg, Rikard The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs |
title | The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs |
title_full | The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs |
title_fullStr | The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs |
title_full_unstemmed | The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs |
title_short | The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs |
title_sort | human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of scfas |
topic | Narrative Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535511/ https://www.ncbi.nlm.nih.gov/pubmed/36026526 http://dx.doi.org/10.1093/ajcn/nqac217 |
work_keys_str_mv | AT palmnasbedardmariesa thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT costabilegiuseppina thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT vetraniclaudia thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT abergsebastian thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT hjalmarssonyommine thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT dicksvedjohan thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT riccardigabriele thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT landbergrikard thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT palmnasbedardmariesa humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT costabilegiuseppina humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT vetraniclaudia humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT abergsebastian humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT hjalmarssonyommine humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT dicksvedjohan humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT riccardigabriele humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas AT landbergrikard humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas |